Cingulate, Inc. (CING)
4.26
+0.02
(+0.47%)
USD |
NASDAQ |
Nov 06, 16:00
4.25
-0.01
(-0.23%)
After-Hours: 20:00
Cingulate Enterprise Value : 37.08M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 37.08M |
| November 05, 2026 | 36.80M |
| November 04, 2026 | 41.25M |
| November 03, 2026 | 43.47M |
| November 02, 2026 | 47.78M |
| October 30, 2026 | 47.08M |
| October 29, 2026 | 50.00M |
| October 28, 2026 | 50.84M |
| October 27, 2026 | 54.73M |
| October 26, 2026 | 49.86M |
| October 23, 2026 | 47.08M |
| October 22, 2026 | 42.64M |
| October 21, 2026 | 42.64M |
| October 20, 2026 | 40.83M |
| October 19, 2026 | 38.47M |
| October 16, 2026 | 38.47M |
| October 15, 2026 | 38.89M |
| October 14, 2026 | 41.39M |
| October 13, 2026 | 43.47M |
| October 12, 2026 | 45.14M |
| October 09, 2026 | 45.83M |
| October 08, 2026 | 45.70M |
| October 07, 2026 | 45.56M |
| October 06, 2026 | 45.83M |
| October 05, 2026 | 43.89M |
| Date | Value |
|---|---|
| October 02, 2026 | 44.03M |
| October 01, 2026 | 43.89M |
| September 30, 2026 | 46.67M |
| September 29, 2026 | 46.04M |
| September 28, 2026 | 44.86M |
| September 25, 2026 | 45.00M |
| September 24, 2026 | 48.20M |
| September 23, 2026 | 47.08M |
| September 22, 2026 | 49.38M |
| September 21, 2026 | 50.56M |
| September 18, 2026 | 50.70M |
| September 17, 2026 | 49.45M |
| September 16, 2026 | 48.61M |
| September 15, 2026 | 48.89M |
| September 14, 2026 | 49.72M |
| September 11, 2026 | 47.64M |
| September 10, 2026 | 49.72M |
| September 09, 2026 | 50.28M |
| September 08, 2026 | 50.00M |
| September 04, 2026 | 48.75M |
| September 03, 2026 | 50.42M |
| September 02, 2026 | 49.45M |
| September 01, 2026 | 48.89M |
| August 31, 2026 | 49.72M |
| August 28, 2026 | 51.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.715B |
| Corcept Therapeutics, Inc. | 7.597B |
| Veru, Inc. | 13.04M |
| Johnson & Johnson | 692.32B |
| Eli Lilly & Co. | 1.319T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.870M |
| Total Expenses (Quarterly) | 5.870M |
| EPS Diluted (Quarterly) | -0.4452 |
| Earnings Yield | -84.88% |
| Normalized Earnings Yield | -79.89 |